David Hogg
University of Siena
2 papers in the Anchorcite directory, published between 2010 and 2017, cited 20,847 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Cutaneous Melanoma Detection and Management · 2 papers
- Immunotherapy and Immune Responses · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Frank Stephen Hodi · 2 papers
- Jeffrey Alan Sosman · 2 papers
- John B.A.G. Haanen · 2 papers
- Rene C. Gonzalez · 2 papers
- Dirk Schadendorf · 2 papers
- Célèste Lebbé · 2 papers
- Jedd D. Wolchok · 2 papers
- Steven J O'Day · 1 paper
Papers
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine · 2010 · 15,401 citations
BACKGROUND: An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab--which blocks cytotoxic T-lymphocyte-associated antigen 4 to potentiate an antitumor T-cell response--administered with or without a glycoprotein 100 (gp100)…
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaNew England Journal of Medicine · 2017 · 5,446 citations
BACKGROUND: Nivolumab combined with ipilimumab resulted in longer progression-free survival and a higher objective response rate than ipilimumab alone in a phase 3 trial involving patients with advanced melanoma. We now report 3-year overall survival outcomes in this trial. METHODS:…
Metadata from OpenAlex (CC0).